Active · per the CBE, 16 September 2026

QBIC Brussels Fund

BE0846785551

Rechtspersoon Public limited company 1 establishment

Witte Patersstraat 4, 1040 Etterbeek

Active for

14 year, 2 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Two loss years in a row NBB

    Negative result in 2024 and 2025.

  • Busy address KBO

    69 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

QBIC Brussels Fund from Etterbeek, company number BE0846785551, closed financial year 2025 with a result of € -13,560 after tax. For that financial year QBIC Brussels Fund recorded a gross margin of € -11,963 and equity of € 2.1 million. Compared with financial year 2024, the result moved from € -300,669 to € -13,560. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 1, 2026.

What it is worth Healthy

€ 2.1 million

▼ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -13,560

▲ 95 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 68,374

▼ 22% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -1.5 million.

People and assets in 2025

Full-time equivalents

0

Average over the fiscal year, from the social balance sheet.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 163

▼ 97% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € 9,052 € -18,882 € -13,115 € -11,963 ▲ € 1,153
Profit after taxes € -598,554 € 194,116 € -300,669 € -13,560 ▲ € 287,110
Equity € 2,254,632 € 2,448,748 € 2,148,078 € 2,134,519 ▼ 1%
Total debts € 2,589 € 31,151 € 35,398 € 30,329 ▼ 14%
Cash € 44,822 € 15,584 € 87,811 € 68,374 ▼ 22%
Retained profit € -1,348,368 € -1,154,252 € -1,454,922 € -1,468,481 ▼ € 13,560
Balance sheet total € 2,257,221 € 2,479,899 € 2,183,476 € 2,164,847 ▼ 1%

Key figures of QBIC Brussels Fund, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to QBIC Brussels Fund?

What happened at QBIC Brussels Fund in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Qbic Venture Partners BV stepped down as director. NBB
  • Jan Cornelis stepped down as director. NBB
  • Finance&invest.brussels NV stepped down as director. NBB
  • ING België NV stepped down as director. NBB
  • Yannik Hallet stepped down as director. NBB
  • Isabelle Cardinael stepped down as director. NBB
  • BNP Paribas Fortis Private Equity Belgium NV stepped down as director. NBB
  • Jean-Pierre Timmermans stepped down as director. NBB

In short

From € 598,554 loss in 2022 to € 13,560 loss in 2025.

Best year ever: 2023, with € 194,116 profit.

Management

The stake of QBIC Feeder Fund, finance&invest.brussels comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

QBIC Brussels Fund

The shares are held by QBIC Feeder Fund (50%) and finance&invest.brussels (22.2%). It owns 5.5% of Ubidata and 2.7% of Confo Therapeutics itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Qbic Venture Partners BV

Managing director · represented by Zabeau Marc

Also active at: Morrow, OVIZIO IMAGING SYSTEMS, QBIC Feeder Fund, QBIC Arkiv Fund, UBIDATA

since 2024 · until 2026

Jan Cornelis

Director

Also active at: QBIC Feeder Fund, QBIC Arkiv Fund

since 2024 · until 2026

Yannik Hallet

Director

since 2024 · until 2026

since 2024 · until 2026

since 2024 · until 2026

Jean-Pierre Timmermans

Director

Also active at: QBIC Feeder Fund, QBIC Arkiv Fund

since 2024 · until 2026

Herman Verwilst

Director

Also active at: QBIC Feeder Fund

since 2024 · until 2026

Steven Coppens

Director

Also active at: QBIC Feeder Fund, QBIC Arkiv Fund

since 2024 · until 2026

Rik Van De Walle

Director

since 2024 · until 2026

Shareholders

finance&invest.brussels · holding of ING België NV

22.2%

Participations

Establishments

Establishment units

Physical locations of this company

Registered office

Witte Patersstraat 4

1040 Etterbeek

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0846.785.551
VAT number
BE 0846.785.551
Registered office
Witte Patersstraat 4, 1040 Etterbeek
Names & denominations
QBIC Brussels Fund
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
22 June 2012
Peppol
Active · Active since 10 Dec 2025

Frequently asked questions

What is the address of QBIC Brussels Fund?
The registered office of QBIC Brussels Fund is located at Witte Patersstraat 4, 1040 Etterbeek.
Is QBIC Brussels Fund still active?
Yes. According to the CBE (16 September 2026) QBIC Brussels Fund is active, legal situation “Normale toestand”, started on 22 June 2012.
Is QBIC Brussels Fund registered on Peppol?
Yes, QBIC Brussels Fund is registered on the Peppol network with ID 0208:0846785551.
What is the enterprise number of QBIC Brussels Fund?
The enterprise number of QBIC Brussels Fund is BE0846785551.
When was QBIC Brussels Fund founded?
QBIC Brussels Fund was founded on 22 June 2012.
Who owns QBIC Brussels Fund?
The shares are held by QBIC Feeder Fund (50%) and finance&invest.brussels (22.2%). It owns 5.5% of Ubidata and 2.7% of Confo Therapeutics itself.